10-Q: Northrop Grumman Reports Lower Q1 2025 Earnings Due to B-21 Program Loss
Quarterly Report
Northrop Grumman's Q1 2025 earnings declined significantly due to a loss provision on the B-21 program and lower sales in Space Systems, despite increased revenue in other segments.
Summary
- Northrop Grumman's Q1 2025 sales decreased by 7% to $9.468 billion compared to $10.133 billion in Q1 2024.
- Operating income decreased by 46% to $573 million, with the operating margin rate declining to 6.1% from 10.6%.
- Net earnings decreased by 49% to $481 million, resulting in diluted earnings per share of $3.32, a 47% decrease.
- The Aeronautics Systems segment reported an operating loss of $183 million due to a $477 million loss provision on the B-21 program.
- The Defense Systems segment saw sales increase by 4% to $1.805 billion and operating income increase by 15% to $179 million.
- Mission Systems sales increased by 6% to $2.807 billion, but operating income decreased by 4% to $361 million.
- Space Systems sales decreased by 18% to $2.568 billion, with operating income decreasing by 14% to $283 million.
- The company's backlog as of March 31, 2025, was $92.8 billion.
- The company recognized an additional $477 million loss across the five LRIP options on the B-21 program, bringing the total loss accrual to $1.7 billion.
- The company expects to reduce 2025 cash from operations by approximately $230 million due to Section 174 of the IRC.
Sentiment
Score: 5
Explanation: The document presents mixed sentiment. While there are positives such as increased sales in some segments and a strong backlog, the significant loss provision on the B-21 program and overall decrease in earnings weigh heavily on the outlook.
Positives
- Defense Systems experienced a 4% increase in sales and a 15% increase in operating income.
- Mission Systems sales increased by 6% due to higher sales on the Scalable Agile Beam Radar (SABR) program and other programs.
- Space Systems operating margin rate increased to 11.0% from 10.5% due to higher net EAC adjustments.
- The company's backlog remains strong at $92.8 billion.
- The company expects to recognize an after-tax gain of approximately $150 million when the transaction to sell substantially all of the Immersive Mission Solutions (IMS) operating unit of Defense Systems closes.
Negatives
- Northrop Grumman's Q1 2025 net earnings decreased 49% to $481 million.
- Aeronautics Systems reported an operating loss of $183 million, impacted by a $477 million loss provision on the B-21 program.
- Space Systems experienced an 18% decrease in sales, primarily due to the wind-down of work on certain programs.
- The company expects to reduce 2025 cash from operations by approximately $230 million due to Section 174 of the IRC.
Risks
- The B-21 program continues to pose a risk, with a remaining loss accrual of $1.7 billion.
- The Sentinel program is undergoing restructuring, and changes to the program baseline could affect future profitability.
- Uncertainties in the U.S. political, budget, and regulatory environment could impact defense spending.
- Macroeconomic factors, including inflationary pressures and supply chain disruptions, could continue to pose challenges.
- The company is involved in various investigations, claims, and litigation, including government investigations and claims, that arise in the ordinary course of our business.
Future Outlook
The company believes its capabilities, particularly in space, C4ISR, missile defense, battle management, advanced weapons, strategic deterrence, and survivable aircraft and mission systems should help its customers in the U.S. and globally defend against current and future threats and, as a result, continue to allow for long-term profitable business growth.
Management Comments
- With the investments we've made in advanced technologies, combined with our talented workforce and digital transformation capabilities, Northrop Grumman is well positioned to meet our customers' needs today and in the future.
Industry Context
The global security environment of heightened tensions and instability, threats from state and non-state actors, increasing nuclear tensions, diverse regional security concerns and political instability are driving the market for defense products, services and solutions globally.
Legal Proceedings
- The company received from the U.S. Department of Justice (DOJ) a criminal subpoena on December 9, 2022, and a civil investigative demand (CID) on February 2, 2023, both seeking information regarding financial and cost accounting and controls that appears focused on the interest rate assumptions the company used to determine our U.S. Government Cost Accounting Standards (CAS) pension expense.
- The company is a party to various other investigations, lawsuits, arbitration, claims, enforcement actions and other legal proceedings, including government investigations and claims, that arise in the ordinary course of our business.
Related Party Transactions
- For all periods presented, the company had no material related party transactions.
Stakeholder Impact
- The lower earnings and loss provision on the B-21 program could negatively impact shareholder value.
- The company's ability to attract and retain a qualified and talented workforce is critical to meeting its performance obligations.
- The company's relationships with its customers, suppliers, and partners are important to its success.
Next Steps
- The company expects to continue discussions with the DOJ and DCMA regarding the interest rate assumptions used to determine our U.S. Government Cost Accounting Standards (CAS) pension expense.
- The company will continue to work to address challenges caused by the macroeconomic environment on our business.
- The company is partnering with our customer to establish a new program baseline as part of the Sentinel program restructuring activities.
Key Dates
| Date | Description |
|---|---|
| 2022-01-24 | Board of directors authorized a share repurchase program of up to $2.0 billion in share repurchases of the company's common stock (the 2022 Repurchase Program). |
| 2023-12-06 | Board of directors authorized a new share repurchase program of up to an additional $2.5 billion in share repurchases of the company's common stock (the 2023 Repurchase Program). |
| 2024-01-29 | The company entered into a definitive agreement to sell substantially all of the Immersive Mission Solutions (IMS) operating unit of Defense Systems for $327 million in cash. |
| 2024-12-11 | Board of directors authorized a new share repurchase program of up to an additional $3.0 billion in share repurchases of the company's common stock (the 2024 Repurchase Program). |
| 2025-01-29 | We previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of financial position of Northrop Grumman Corporation and subsidiaries as of December 31, 2024, and the related consolidated statements of earnings and comprehensive income, changes in shareholders equity, and cash flows for the year then ended (not presented herein); and in our report dated January 29, 2025, we expressed an unqualified opinion on those consolidated financial statements. |
| 2025-01-29 | On January 29, 2025, the company entered into a definitive agreement to sell substantially all of the Immersive Mission Solutions (IMS) operating unit of Defense Systems for $327 million in cash. |
| 2025-01-29 | In our opinion, the information set forth in the accompanying condensed consolidated statement of financial position as of December 31, 2024, is fairly stated, in all material respects, in relation to the audited consolidated statement of financial position from which it has been derived. |
| 2025-01-29 | We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of financial position of Northrop Grumman Corporation and subsidiaries as of December 31, 2024, and the related consolidated statements of earnings and comprehensive income, changes in shareholders equity, and cash flows for the year then ended (not presented herein); and in our report dated January 29, 2025, we expressed an unqualified opinion on those consolidated financial statements. |
| 2025-01-29 | We are aware that our report dated April 21, 2025, on our review of the interim financial information of Northrop Grumman Corporation and subsidiaries appearing in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, is incorporated by reference in Registration Statement Nos. 033-59815, 033-59853, 333-67266, 333-100179, 333-107734, 333-121104, 333-125120, 333-127317, 333-175798, 333-273482, and 333-281008 on Form S-8, 333-270497 on Form S-3, and 333-264549 on Form S-4. |
| 2025-02-18 | The terms of this amended and restated Plan are applicable to Qualifying Terminations that occur on or after February 18, 2025. |
| 2025-03-15 | On March 15, 2025, the Full-Year Continuing Appropriations and Extensions Act, 2025 was enacted to continue funding the government through the remainder of FY 2025. |
| 2025-04-09 | On April 9, 2025, the President signed an executive order entitled Modernizing Defense Acquisitions and Spurring Innovation in the Defense Industrial Base. |
| 2025-04-17 | As of April 17, 2025, 143,928,185 shares of common stock were outstanding. |
| 2025-04-21 | We are aware that our report dated April 21, 2025, on our review of the interim financial information of Northrop Grumman Corporation and subsidiaries appearing in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, is incorporated by reference in Registration Statement Nos. 033-59815, 033-59853, 333-67266, 333-100179, 333-107734, 333-121104, 333-125120, 333-127317, 333-175798, 333-273482, and 333-281008 on Form S-8, 333-270497 on Form S-3, and 333-264549 on Form S-4. |
Keywords
Northrop Grumman, earnings, B-21 program, Sentinel program, sales, operating income, backlog, defense, aerospace, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.